Aura Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AURA and other ETFs, options, and stocks.About AURA
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities.
AURA Key Statistics
Stock Snapshot
With a market cap of 419.22M, Aura Biosciences(AURA) trades at $6.54. The stock has a price-to-earnings ratio of -3.61.
On 2026-04-03, Aura Biosciences(AURA) stock moved within a range of $6.54 to $6.79. With shares now at $6.54, the stock is trading +0.1% above its intraday low and -3.7% below the session's peak.
Trading activity shows a volume of 174.6K, compared to an average daily volume of 276.54K.
The stock's 52-week range extends from a low of $4.35 to a high of $7.48.
The stock's 52-week range extends from a low of $4.35 to a high of $7.48.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.